Background Immunological disturbances are hypothesised to are likely involved in recurrent miscarriage (RM) and therefore intravenous immunoglubulins (IVIg) have been tested in RM patients. (RR 0.92, 95% CI 0.75C1.12, p = 0.42). Trial sequential analysis showed that the required information size of 1 1,008 participants was not obtained. IVIg compared with placebo seems to increase… Continue reading Background Immunological disturbances are hypothesised to are likely involved in recurrent